Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

20.93
+0.14500.70%
Volume:29.06K
Turnover:605.45K
Market Cap:1.87B
PE:-8.34
High:20.97
Open:20.85
Low:20.70
Close:20.78
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:1.24
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:123.75
PE(LYR):-6.35

Loading ...

Stock Track | Syndax Pharmaceuticals Plummets 6.38% Intraday Following Q1 Revenue Miss

Stock Track
·
May 01

Syndax price target raised to $37 from $35 at Barclays

TIPRANKS
·
May 01

Barclays Sticks to Their Buy Rating for Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
May 01

Syndax Pharmaceuticals announces annual shareholder meeting webcast

Reuters
·
May 01

Earnings Flash (SNDX) Syndax Pharmaceuticals Posts Q1 Loss $0.48, vs. FactSet Est of $0.61 Loss

MT Newswires Live
·
May 01

Stock Track | Syndax Pharmaceuticals Plunges 6.67% After-Hours on Mixed Q1 Earnings with Sales Miss

Stock Track
·
May 01

Syndax Q1 revenue jumps on cancer drug sales

Reuters
·
May 01

Syndax Pharmaceuticals Q1 EPS $(0.48) Beats $(0.64) Estimate, Sales $64.864M Miss $70.439M Estimate

Benzinga Earnings
·
May 01

BRIEF-Syndax Pharmaceuticals Q1 Operating Expenses USD 99.066 Million

Reuters
·
May 01

Syndax Pharmaceuticals: Total Revenue of $64.9 Million in 1Q26, a 224% Year-Over-Year Increase

THOMSON REUTERS
·
May 01

Syndax Pharmaceuticals Q1 Operating Income USD -34.202 Million

THOMSON REUTERS
·
May 01

Syndax Pharmaceuticals Q1 Cash & Investments USD 352.1 Million

THOMSON REUTERS
·
May 01

Syndax Reports First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 01

Top 20 US Stocks by Trading Volume on April 28: OpenAI Ends Exclusive Partnership with Microsoft

Deep News
·
Apr 28

Syndax to report Q1 results, host conference call and webcast

Reuters
·
Apr 24

Sandisk, Lumentum Rally Sparks Bearish Plays As Tradr Rolls Out 2X Short ETFs

Benzinga_recent_news
·
Apr 24

Micron Technology Hits Record High on Strong Earnings Outlook, Goldman Sachs Bullish

Deep News
·
Apr 23

Syndax Pharmaceuticals (SNDX) Receives a Buy from Barclays

TIPRANKS
·
Apr 21

Morgan Stanley: Why Storage Stocks Offer Superior Risk-Reward Over CPU Investments

Deep News
·
Apr 21

Assessing Syndax Pharmaceuticals (SNDX) Valuation After A 110% One Year Return

Simply Wall St.
·
Apr 19